Tuition and Financial Aid

Page Image

Page Content

Admission to the program includes financial support via a stipend awarded on a 12-month basis. The student stipend for 2014-2015 is $27,000 per year. Based on the rules of the UCD Graduate School, all PhD students in good academic standing are guaranteed financial support.

Although a priority of the School of Pharmacy is to provide financial support to its graduate students, payment of stipend, tuition and any fees by the School of Pharmacy or by grants, contracts or gifts to the School of Pharmacy faculty is contingent upon satisfactory academic progress (as defined by the UCD Graduate School, Graduate Student Handbook) and completion of required teaching duties, core courses, research rotations, seminars, and examinations (as listed on the progress report form). The School of Pharmacy also reserves the right to review and adjust its funding policies at any time. All students are expected to work full-time toward program requirements for 12 months of the year.

Generally, the first year of financial support will be in the form of stipend support for working as a teaching assistant. Depending on availability, teaching assistantships may be offered beyond one year to students. Faculty may choose to offer research assistant scholarships to students as well. Other funding opportunities in the form of external student grants and awards also exist. Students are encouraged to talk to the faculty about funding and scholarship opportunities. Funds for travel to one meeting where students are presenting a poster or giving a podium presentation are limited to $500 per fiscal year.

Students who do not remain in good graduate standing (3.0 GPA or above) or maintain satisfactory academic progress are placed on academic probation. Probation and suspension policies are described in the UCD Graduate School, Graduate Student Handbook. Payment of stipend, tuition, insurance and fees for a student while on academic probation is at the discretion of the graduate program committee.